Anti-Staphylococcus Epidermidis Lipoteichoic Acid Recombinant Antibody
-
产品编号
YR1165
-
别名
科研级 Pagibaximab ( 帕昔单抗 ), Anti-Lipoteichoic Acid Recombinant Antibody, Research Grade Pagibaximab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Pagibaximab ( 帕昔单抗 ), Anti-Lipoteichoic Acid Recombinant Antibody, Research Grade Pagibaximab |
| Catalog Number | YR1165 |
| Molecular Name | Pagibaximab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight. As of March 2010, it is undergoing Phase II/III clinical trials. |
| CAS Number | 595566-61-3 |
| Application | FuncS, IF, Neut, ELISA, FCM, IP |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | Lipoteichoic Acid[Staphylococcus epidermidis] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
